Shanghai Pharmaceuticals Holding Co Ltd (601607) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co Ltd (601607) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.56 Billion ≈ $227.99 Million USD) by net assets (CN¥89.62 Billion ≈ $13.11 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Pharmaceuticals Holding Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Shanghai Pharmaceuticals Holding Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Pharmaceuticals Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Shanghai Pharmaceuticals Holding Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shanghai Pharmaceuticals Holding Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Pharmaceuticals Holding Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NOV Inc. NYSE:NOV	-0.004x
Yangzhou Yangjie Electronic Technology Co Ltd SHE:300373	0.026x
Stora Enso Oyj R HE:STERV	0.025x
Pilgrims Pride Corp NASDAQ:PPC	0.079x
Definity Financial Corp TO:DFY	-0.030x
Hyundai Autoever Corp KO:307950	0.082x
Prosperity Bancshares Inc NYSE:PB	0.010x
Godrej Properties Limited NSE:GODREJPROP	-0.155x

Annual Cash Flow Conversion Efficiency for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai Pharmaceuticals Holding Co Ltd (601607) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥89.79 Billion ≈ $13.14 Billion	CN¥6.15 Billion ≈ $900.55 Million	0.069x	-1.50%
2024-12-31	CN¥83.74 Billion ≈ $12.25 Billion	CN¥5.83 Billion ≈ $852.71 Million	0.070x	+6.84%
2023-12-31	CN¥80.33 Billion ≈ $11.75 Billion	CN¥5.23 Billion ≈ $765.54 Million	0.065x	+7.10%
2022-12-31	CN¥78.00 Billion ≈ $11.41 Billion	CN¥4.74 Billion ≈ $694.10 Million	0.061x	-29.03%
2021-12-31	CN¥59.07 Billion ≈ $8.64 Billion	CN¥5.06 Billion ≈ $740.63 Million	0.086x	-31.47%
2020-12-31	CN¥54.74 Billion ≈ $8.01 Billion	CN¥6.84 Billion ≈ $1.00 Billion	0.125x	+2.54%
2019-12-31	CN¥49.39 Billion ≈ $7.23 Billion	CN¥6.02 Billion ≈ $881.26 Million	0.122x	+80.61%
2018-12-31	CN¥46.43 Billion ≈ $6.79 Billion	CN¥3.14 Billion ≈ $458.77 Million	0.068x	+1.13%
2017-12-31	CN¥39.68 Billion ≈ $5.81 Billion	CN¥2.65 Billion ≈ $387.60 Million	0.067x	+26.32%
2016-12-31	CN¥36.83 Billion ≈ $5.39 Billion	CN¥1.95 Billion ≈ $284.86 Million	0.053x	+32.43%
2015-12-31	CN¥33.81 Billion ≈ $4.95 Billion	CN¥1.35 Billion ≈ $197.42 Million	0.040x	-7.08%
2014-12-31	CN¥31.10 Billion ≈ $4.55 Billion	CN¥1.34 Billion ≈ $195.45 Million	0.043x	+27.95%
2013-12-31	CN¥29.00 Billion ≈ $4.24 Billion	CN¥973.45 Million ≈ $142.45 Million	0.034x	-19.20%
2012-12-31	CN¥27.70 Billion ≈ $4.05 Billion	CN¥1.15 Billion ≈ $168.39 Million	0.042x	-39.10%
2011-12-31	CN¥25.98 Billion ≈ $3.80 Billion	CN¥1.77 Billion ≈ $259.36 Million	0.068x	-51.92%
2010-12-31	CN¥11.88 Billion ≈ $1.74 Billion	CN¥1.69 Billion ≈ $246.73 Million	0.142x	-50.39%
2009-12-31	CN¥2.32 Billion ≈ $339.84 Million	CN¥664.13 Million ≈ $97.18 Million	0.286x	+109.19%
2008-12-31	CN¥2.09 Billion ≈ $305.80 Million	CN¥285.68 Million ≈ $41.80 Million	0.137x	-45.25%
2007-12-31	CN¥1.96 Billion ≈ $286.56 Million	CN¥488.94 Million ≈ $71.55 Million	0.250x	-11.50%
2006-12-31	CN¥2.07 Billion ≈ $302.45 Million	CN¥583.11 Million ≈ $85.33 Million	0.282x	+675.17%
2005-12-31	CN¥2.01 Billion ≈ $293.52 Million	CN¥73.00 Million ≈ $10.68 Million	0.036x	+21.65%
2004-12-31	CN¥2.06 Billion ≈ $301.60 Million	CN¥61.66 Million ≈ $9.02 Million	0.030x	+13043.04%
2003-12-31	CN¥2.13 Billion ≈ $311.31 Million	CN¥484.27K ≈ $70.86K	0.000x	-99.55%
2002-12-31	CN¥2.00 Billion ≈ $292.60 Million	CN¥100.84 Million ≈ $14.76 Million	0.050x	+39.50%
2001-12-31	CN¥1.82 Billion ≈ $266.06 Million	CN¥65.73 Million ≈ $9.62 Million	0.036x	-75.64%
2000-12-31	CN¥985.30 Million ≈ $144.18 Million	CN¥146.22 Million ≈ $21.40 Million	0.148x	-23.41%
1999-12-31	CN¥849.92 Million ≈ $124.37 Million	CN¥164.67 Million ≈ $24.10 Million	0.194x	+148.82%
1998-12-31	CN¥713.42 Million ≈ $104.40 Million	CN¥-283.14 Million ≈ $-41.43 Million	-0.397x	--

About Shanghai Pharmaceuticals Holding Co Ltd

SHG:601607 China Medical Distribution

Market Cap

$6.91 Billion

CN¥47.19 Billion CNY

Market Cap Rank

#2870 Global

#347 in China

Share Price

CN¥16.92

Change (1 day)

+1.87%

52-Week Range

CN¥15.29 - CN¥19.48

All Time High

CN¥25.03